Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.

Faries MB, Han D, Reintgen M, Kerivan L, Reintgen D, Carac├▓ C.

Clin Exp Metastasis. 2018 May 18. doi: 10.1007/s10585-018-9898-6. [Epub ahead of print]

PMID:
29777421
2.

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-╬▒-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).

Agarwala SS, Lee SJ, Yip W, Rao UN, Tarhini AA, Cohen GI, Reintgen DS, Evans TL, Brell JM, Albertini MR, Atkins MB, Dakhil SR, Conry RM, Sosman JA, Flaherty LE, Sondak VK, Carson WE, Smylie MG, Pappo AS, Kefford RF, Kirkwood JM.

J Clin Oncol. 2017 Mar 10;35(8):885-892. doi: 10.1200/JCO.2016.70.2951. Epub 2017 Jan 30.

3.

Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities.

Rodhouse C, Soliman I, Cruse M, Kastrenakes J, Augustine CJ, Ludy A, Reintgen E, Hoadley A, Desai D, Nguyen M, Reintgen DS.

Clin Breast Cancer. 2017 Feb;17(1):18-22. doi: 10.1016/j.clbc.2016.10.007. Epub 2016 Oct 19.

PMID:
27864044
4.

Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy.

Swaminathan S, Reintgen M, Kerivan L, Reintgen E, Smith J, Reintgen D.

Clin Breast Cancer. 2016 Jun;16(3):e65-8. doi: 10.1016/j.clbc.2016.02.015. Epub 2016 Feb 11. No abstract available.

PMID:
26993215
5.

Breast Lymphatic Mapping and Sentinel Lymph Node Biopsy: State of the Art: 2015.

Reintgen M, Kerivan L, Reintgen E, Swaninathan S, Reintgen D.

Clin Breast Cancer. 2016 Jun;16(3):155-65. doi: 10.1016/j.clbc.2016.02.014. Epub 2016 Feb 11. Review.

PMID:
26952594
6.

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.

McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.

J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.

7.

Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma.

Egger ME, Bower MR, Czyszczon IA, Farghaly H, Noyes RD, Reintgen DS, Martin RC 2nd, Scoggins CR, Stromberg AJ, McMasters KM.

J Am Coll Surg. 2014 Apr;218(4):519-28. doi: 10.1016/j.jamcollsurg.2013.12.014. Epub 2013 Dec 21.

PMID:
24491245
8.

Breast preservation in women with giant juvenile fibroadenoma.

Matz D, Kerivan L, Reintgen M, Akman K, Lozicki A, Causey T, Clynes C, Giuliano R, Acs G, Cox J, Cox C, Reintgen D.

Clin Breast Cancer. 2013 Jun;13(3):219-22. doi: 10.1016/j.clbc.2012.10.003. Epub 2012 Dec 14. No abstract available.

PMID:
23245878
9.

Diversity of stage III melanoma in the era of sentinel lymph node biopsy.

Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR.

Ann Surg Oncol. 2013 Mar;20(3):956-63. doi: 10.1245/s10434-012-2701-z. Epub 2012 Oct 14.

PMID:
23064795
10.

Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.

Reintgen M, Murray L, Akman K, Giuliano R, Lozicki A, Shivers S, Reintgen D.

Ann Surg Oncol. 2013 Feb;20(2):668-74. doi: 10.1245/s10434-012-2652-4. Epub 2012 Oct 5.

PMID:
23054112
11.

Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).

Howard JH, Thompson JF, Mozzillo N, Nieweg OE, Hoekstra HJ, Roses DF, Sondak VK, Reintgen DS, Kashani-Sabet M, Karakousis CP, Coventry BJ, Kraybill WG, Smithers BM, Elashoff R, Stern SL, Cochran AJ, Faries MB, Morton DL.

Ann Surg Oncol. 2012 Aug;19(8):2547-55. doi: 10.1245/s10434-012-2398-z. Epub 2012 May 31.

12.

Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity.

Murray L, Reintgen M, Akman K, Cox C, Cox J, Reintgen D, Greenberg H, Vrcel V.

Clin Breast Cancer. 2012 Feb;12(1):76-9. doi: 10.1016/j.clbc.2011.08.007. Epub 2011 Oct 29. No abstract available.

PMID:
22037287
13.

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.

Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote R.

JAMA. 2011 Jul 27;306(4):385-93. doi: 10.1001/jama.2011.1034.

14.

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P.

N Engl J Med. 2011 Jun 2;364(22):2119-27. doi: 10.1056/NEJMoa1012863.

15.

A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.

Kirkwood JM, Gonzalez R, Reintgen D, Clingan PR, McWilliams RR, de Alwis DP, Zimmermann A, Brown MP, Ilaria RL Jr, Millward MJ.

Cancer. 2011 Oct 15;117(20):4732-9. doi: 10.1002/cncr.26068. Epub 2011 Mar 31.

16.

Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.

McMasters KM, Edwards MJ, Ross MI, Reintgen DS, Martin RC 2nd, Urist MM, Noyes RD, Sussman JJ, Stromberg AJ, Scoggins CR.

Ann Surg. 2010 Sep;252(3):460-5; discussion 465-6. doi: 10.1097/SLA.0b013e3181f20bb1.

PMID:
20739846
17.

Second primary melanomas: incidence and outcome.

Bower MR, Scoggins CR, Martin RC 2nd, Mays MP, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Noyes RD, Sussman JJ, Hagendoorn LJ, Stromberg AJ, McMasters K.

Am Surg. 2010 Jul;76(7):675-81.

PMID:
20698369
18.

The prognostic significance of nonsentinel lymph node metastasis in melanoma.

Brown RE, Ross MI, Edwards MJ, Noyes RD, Reintgen DS, Hagendoorn LJ, Stromberg AJ, Martin RC, McMasters KM, Scoggins CR.

Ann Surg Oncol. 2010 Dec;17(12):3330-5. doi: 10.1245/s10434-010-1208-8. Epub 2010 Jul 20.

PMID:
20645010
19.

Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.

Scoggins CR, Bowen AL, Martin RC 2nd, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, Hagendoorn L, McMasters KM.

Arch Surg. 2010 Jul;145(7):622-7. doi: 10.1001/archsurg.2010.115.

PMID:
20644123
20.

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ, Morton DL; MSLT Cooperative Group.

Ann Surg Oncol. 2010 Dec;17(12):3324-9. doi: 10.1245/s10434-010-1203-0. Epub 2010 Jul 8.

21.

Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field.

Reintgen C, Reintgen D, Solin LJ.

Clin Breast Cancer. 2010 Jun;10(3):180-7. doi: 10.3816/CBC.2010.n.025. Review.

PMID:
20497916
22.

The changing face of malignant melanoma.

Reintgen C, Shivers S, Reintgen M, Giuliano R, Reintgen D.

J Surg Oncol. 2010 May 1;101(6):443-6. doi: 10.1002/jso.21515.

PMID:
20401913
23.

Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.

Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KK.

Ann Surg Oncol. 2010 Aug;17(8):1989-94. doi: 10.1245/s10434-010-0980-9. Epub 2010 Mar 23.

24.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

25.

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion.

Reintgen M, Reintgen C, Nobo C, Giuliano R, Shivers S, Reintgen D.

Cancers (Basel). 2010 Feb 10;2(1):43-50. doi: 10.3390/cancers20100043.

26.

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.

Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.

Ann Surg Oncol. 2010 Mar;17(3):709-17. doi: 10.1245/s10434-009-0858-x. Epub 2009 Dec 5.

PMID:
19967459
27.

Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.

Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.

Ann Surg Oncol. 2010 Feb;17(2):552-7. doi: 10.1245/s10434-009-0800-2.

PMID:
19957043
28.

Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.

Kiluk JV, Ly QP, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.

Ann Surg Oncol. 2011 Dec;18 Suppl 3:S339-42. doi: 10.1245/s10434-009-0704-1. Epub 2009 Sep 24.

PMID:
19777181
29.

The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.

Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS.

Ann Surg Oncol. 2009 Aug;16(8):2245-51. doi: 10.1245/s10434-009-0530-5. Epub 2009 Jun 11.

PMID:
19517194
30.

Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.

Olson JA Jr, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group Trials Z0010 and Z0011.

J Clin Oncol. 2008 Jul 20;26(21):3530-5. doi: 10.1200/JCO.2007.15.5630.

PMID:
18640934
31.

Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.

Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, Rosenberg A, Chagpar AB, Reintgen D, Beitsch P, Simmons R, Saha S, Mamounas EP, Giuliano A.

J Clin Oncol. 2008 Jul 10;26(20):3338-45. doi: 10.1200/JCO.2007.14.0665.

PMID:
18612150
32.

Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.

Lewis JM, Zager JS, Yu D, Pelaez D, Riker AI, Dessureault S, Cruse CW, Reintgen DS, Puleo CA, Sondak VK.

Ann Surg Oncol. 2008 Jun;15(6):1733-40. doi: 10.1245/s10434-008-9887-0. Epub 2008 Apr 1.

PMID:
18379848
33.

Molecular staging for patients with malignant melanoma.

Shivers S, Jakub J, Pendas S, Reintgen D.

Expert Rev Anticancer Ther. 2007 Nov;7(11):1665-74.

PMID:
18020932
34.

Patterns of metastasis in human solid cancers.

Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Werner JA, Kitagawa Y.

Cancer Treat Res. 2007;135:209-21. Review. No abstract available.

PMID:
17953419
35.

Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.

Chagpar RB, Ross MI, Reintgen DS, Edwards MJ, Scoggins CR, Martin RC 2nd, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, McMasters KM.

J Surg Res. 2007 Nov;143(1):164-8.

PMID:
17950088
36.

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors.

Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, Chagpar A, Julian T, Saha S, Mamounas E, Giuliano A, Simmons R.

Am J Surg. 2007 Oct;194(4):426-32.

PMID:
17826050
37.

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group.

J Clin Oncol. 2007 Aug 20;25(24):3657-63. Epub 2007 May 7.

PMID:
17485711
38.

Regional node dissection for melanoma: techniques and indication.

Jakub JW, Reintgen DS, Shivers S, Pendas S.

Surg Oncol Clin N Am. 2007 Jan;16(1):247-61. Review.

PMID:
17336247
39.

Sentinel-node biopsy or nodal observation in melanoma.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ; MSLT Group.

N Engl J Med. 2006 Sep 28;355(13):1307-17. Erratum in: N Engl J Med. 2006 Nov 2;355(18):1944.

40.

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database.

Khan MA, Andrews S, Ismail-Khan R, Munster PN, Brem S, King J, Reintgen DS, Sondak VK, Daud AI.

Cancer Control. 2006 Jul;13(3):211-7.

PMID:
16885917
41.

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Davidson BS, Sussman JJ, Edwards MJ, Martin RC, Lewis AM, Stromberg AJ, Conrad AJ, Hagendoorn L, Albrecht J, McMasters KM.

J Clin Oncol. 2006 Jun 20;24(18):2849-57.

PMID:
16782924
42.

Clinical patterns of metastasis.

Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M.

Cancer Metastasis Rev. 2006 Jun;25(2):221-32. Review.

PMID:
16770534
43.

Molecular mechanisms of metastasis.

Hoon DS, Kitago M, Kim J, Mori T, Piris A, Szyfelbein K, Mihm MC Jr, Nathanson SD, Padera TP, Chambers AF, Vantyghem SA, MacDonald IC, Shivers SC, Alsarraj M, Reintgen DS, Passlick B, Sienel W, Pantel K.

Cancer Metastasis Rev. 2006 Jun;25(2):203-20. Review.

PMID:
16770533
44.

Gender-related differences in outcome for melanoma patients.

Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RC, Stromberg AJ, Hagendoorn L, McMasters KM; Sunbelt Melanoma Trial.

Ann Surg. 2006 May;243(5):693-8; discussion 698-700.

45.

Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.

Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D.

Ann Surg Oncol. 2006 Jun;13(6):809-16. Epub 2006 Apr 12.

46.

Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.

Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE 2nd, Giuliano AE.

Ann Surg Oncol. 2006 Apr;13(4):491-500. Epub 2006 Mar 2.

PMID:
16514477
47.

Is incisional biopsy of melanoma harmful?

Martin RC 2nd, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters KM.

Am J Surg. 2005 Dec;190(6):913-7.

PMID:
16307945
48.

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ; Multicenter Selective Lymphadenectomy Trial Group.

Ann Surg. 2005 Sep;242(3):302-11; discussion 311-3.

49.

Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping.

Jakub JW, Ebert MD, Cantor A, Gardner M, Reintgen DS, Dupont EL, Cox CE, Shons AR.

Plast Reconstr Surg. 2004 Dec;114(7):1737-42.

PMID:
15577343
50.

Molecular staging of melanoma.

Shivers S, Alsarraj M, Guiliano R, Jakub J, Pendas S, Reintgen D.

Ann Surg Oncol. 2004 Nov;11(11):953-4. No abstract available.

PMID:
15525822

Supplemental Content

Loading ...
Support Center